Stay up to date on today's novel bioprocessing technologies by attending this year's BioProcess International Conference & Exhibition, Sept 27-30, 2022 in Boston.
See the full exhibitor list and book your ticket today at:
https://t.co/i9HriM0CnX
#bpiconf#biotechweekboston
Join us tomorrow for a special multi-speaker webcast: The State of National Healthcare Policy and Pricing Webinar 2023
On Jan 25th, at 12:00 pm EST.
Sign up now: https://t.co/4TO80qZFAC
Join us for a special multi-speaker webcast: The State of National Healthcare Policy and Pricing Webinar 2023
On Jan 25th, at 12:00 pm EST.
Sign up now: https://t.co/4TO80qZFAC
Join us today for "Bringing Inovative Analytical Science and Informatics Together to Power Modern Biologics Development" on Jan 18, 2023 at 11:00 AM EST with @ResiliencePharm, an innovative biotechnology company.
Sign up now: https://t.co/BHY8NrYMqI
Join us for a special multi-speaker webcast: The State of National Healthcare Policy and Pricing Webinar 2023
On Jan 25th, at 12:00 pm EST.
Sign up now: https://t.co/4TO80qZFAC
Join us for "Bringing Inovative Analytical Science and Informatics Together to Power Modern Biologics Development" on Jan 18, 2023 at 11:00 AM EST with @ResiliencePharm, an innovative biotechnology company.
Sign up now: https://t.co/HzimnYscDB
Join us for "Bringing Inovative Analytical Science and Informatics Together to Power Modern Biologics Development" on Jan 18, 2023 at 11:00 AM EST with @ResiliencePharm, an innovative biotechnology company.
Sign up now: https://t.co/o7FoCrZ1bB
Join us for "Bringing Inovative Analytical Science and Informatics Together to Power Modern Biologics Development" on Jan 18, 2023 at 11:00 AM EST with @ResiliencePharm, an innovative biotechnology company.
Sign up now: https://t.co/FrQgMAhrWH
Watch Now: https://t.co/lDObCWoGgk
CPI aims to accelerate the manufacture of your biologic candidate by supporting the design, development, optimisation and demonstration of bespoke manufacturing processes specific for your product. Watch to find out how.
Watch now: Cooley partner Shamis Beckley discusses Cooley's commitment to diversity, equity and inclusion within the firm, the broader industry and the community.
https://t.co/GNi73wpep6
Watch Now: https://t.co/IVXMaCHfOs
In this interview, Erik Vaessen, Chief Business Officer, Life Science Business Unit discusses the expansion of FUJIFILM Irvine Scientific’s innovation and capabilities through the R&D Cell Culture of Excellence.
Watch Now: https://t.co/U5UXurF9An
Avantor’s Dr. Ger Brophy shares thoughts on overcoming bioproduction challenges, how biomanufacturers can better work with their suppliers as they develop new treatments and therapies, and the future of the evolving cell and gene therapy market.
Watch Now: https://t.co/qmDpi0XhOb
Avantor’s Dr. Ger Brophy shares thoughts on overcoming bioproduction challenges, how biomanufacturers can better work with their suppliers as they develop new treatments and therapies, and the future of the evolving cell and gene therapy market.
Watch Now: https://t.co/yaVfQvfe0Z
Avantor’s Dr. Ger Brophy shares thoughts on overcoming bioproduction challenges, how biomanufacturers can better work with their suppliers as they develop new treatments and therapies, and the future of the evolving cell and gene therapy market.
Watch Now: https://t.co/tzUJjPWPnu
Avantor’s Dr. Ger Brophy shares thoughts on overcoming bioproduction challenges, how biomanufacturers can better work with their suppliers as they develop new treatments and therapies, and the future of the evolving cell and gene therapy market.
Watch Now: https://t.co/9WyVcZryPd
Avantor’s Dr. Ger Brophy shares thoughts on overcoming bioproduction challenges, how biomanufacturers can better work with their suppliers as they develop new treatments and therapies, and the future of the evolving cell and gene therapy market.
Watch Now: Cooley's commitment to Diversity
Cooley partner Shamis Beckley discusses Cooley's commitment to diversity, equity and inclusion within the firm, the broader industry and the community.
https://t.co/1T7DqMV3vy
Watch Now: https://t.co/c8DbUtFYtH
Avantor’s Dr. Ger Brophy shares thoughts on overcoming bioproduction challenges, how biomanufacturers can better work with their suppliers as they develop new treatments and therapies, and the future of the evolving cell and gene therapy market.
Watch Now: https://t.co/m2yUFfzoTL
Avantor’s Dr. Ger Brophy shares thoughts on overcoming bioproduction challenges, how biomanufacturers can better work with their suppliers as they develop new treatments and therapies, and the future of the evolving cell and gene therapy market.